Skip to main navigation
Skip to search
Skip to main content
WashU Research Profiles Home
Help & FAQ
!!Link opens in a new tab
!!Search content at WashU Research Profiles
Home
Profiles
Research units
Research output
Antimicrobial stewardship in neonates: Challenges and opportunities
Christopher McPherson
, Caren Liviskie
, Brandy Zeller
, Miranda P. Nelson
, Jason G. Newland
Institute of Clinical and Translational Sciences (ICTS)
Division of Infectious Disease
Research output
:
Contribution to journal
›
Article
›
peer-review
18
!!Link opens in a new tab
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Antimicrobial stewardship in neonates: Challenges and opportunities'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Neonate
100%
Antimicrobial Stewardship
100%
Antibiotic Duration
100%
Patient Outcomes
50%
Antibiotic Use
50%
Vancomycin
50%
Empiric Antibiotics
50%
Antibiotics
50%
Antibiotic Resistance
50%
Superior Approach
50%
Positive Culture
50%
Blood Culture
50%
Decision Tree
50%
Aminoglycosides
50%
Multidrug-resistant Organisms
50%
Clinical Indications
50%
Adverse Drug Reaction
50%
Infection Treatment
50%
Empirical Therapy
50%
Neonatal Infection
50%
Immediately after Birth
50%
Risk Stratification System
50%
Sustained Impact
50%
Antistaphylococcal Penicillins
50%
Broad-spectrum Agents
50%
Transparent Systems
50%
Online Risks
50%
Unit Culture
50%
Interprofessional Teams
50%
Pharmacokinetic Study
50%
Third-generation Cephalosporins
50%
Gentamicin
50%
Ampicillin
50%
Gram-negative Meningitis
50%
Neonatal Microbiome
50%
Late-onset Sepsis
50%
Early-onset Sepsis
50%
Medicine and Dentistry
Neonate
100%
Antimicrobial Agent
100%
Antimicrobial Stewardship
100%
Sepsis
66%
Antibiotics
66%
Empirical evidence
66%
Infection
33%
Clinician
33%
Vancomycin
33%
Risk Stratification
33%
Antibiotic Resistance
33%
Blood Culture
33%
Microbiome
33%
Adverse Drug Reaction
33%
Pharmacokinetics
33%
Aminoglycoside
33%
Meningitis
33%
Newborn Infection
33%
Morbidity
33%
Gentamicin
33%
Ampicillin
33%
Antistaphylococcal Penicillins
33%
Third Generation Cephalosporin
33%
Nursing and Health Professions
Neonate
100%
Antimicrobial Stewardship
100%
Antimicrobial Agent
100%
Sepsis
66%
Infection
33%
Vancomycin
33%
Treatment Outcome
33%
Blood Culture
33%
Decision Trees
33%
Meningitis
33%
Newborn Infection
33%
Adverse Drug Reaction
33%
Cephalosporin Derivative
33%
Gentamicin
33%
Aminoglycoside
33%
Ampicillin
33%
Morbidity
33%
Antibiotic Resistance
33%
Collaboration
33%
Microbiome
33%
Pharmacology, Toxicology and Pharmaceutical Science
Antiinfective Agent
100%
Antimicrobial Agent
100%
Sepsis
66%
Antibiotics
66%
Infection
33%
Microbiome
33%
Adverse Drug Reaction
33%
Vancomycin
33%
Meningitis
33%
Morbidity
33%
Newborn Infection
33%
Aminoglycoside
33%
Gentamicin
33%
Ampicillin
33%
Pharmacokinetics
33%
Antibiotic Resistance
33%
Third Generation Cephalosporin
33%
Penicillin
33%